CX3C Chemokine Receptor 1
"CX3C Chemokine Receptor 1" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Receptor for CHEMOKINE CX3CL1 expressed by lymphocytes, neurons, and GLIAL CELLS. Its interaction with CX3CL1 mediates CELL ADHESION and CELL MIGRATION. It also functions as a co-receptor with the CD4 ANTIGEN for HIV-1 in vitro.
| Descriptor ID |
D000073883
|
| MeSH Number(s) |
D12.776.543.750.695.160.500.150 D12.776.543.750.705.852.125.500.150 D12.776.543.750.830.700.315
|
| Concept/Terms |
CX3C Chemokine Receptor 1- CX3C Chemokine Receptor 1
- CX3C Receptor
- Receptor, CX3C
- V28 Receptor
- CX(3)CR1
- Receptor, V28
- Fractalkine Receptor
- Receptor, Fractalkine
- CX(3)C Receptor
- V28 Receptors
- Receptors, V28
|
Below are MeSH descriptors whose meaning is more general than "CX3C Chemokine Receptor 1".
- Chemicals and Drugs [D]
- Amino Acids, Peptides, and Proteins [D12]
- Proteins [D12.776]
- Membrane Proteins [D12.776.543]
- Receptors, Cell Surface [D12.776.543.750]
- Receptors, G-Protein-Coupled [D12.776.543.750.695]
- Receptors, Chemokine [D12.776.543.750.695.160]
- Receptors, CXCR [D12.776.543.750.695.160.500]
- CX3C Chemokine Receptor 1 [D12.776.543.750.695.160.500.150]
- Receptors, Immunologic [D12.776.543.750.705]
- Receptors, Cytokine [D12.776.543.750.705.852]
- Receptors, Chemokine [D12.776.543.750.705.852.125]
- Receptors, CXCR [D12.776.543.750.705.852.125.500]
- CX3C Chemokine Receptor 1 [D12.776.543.750.705.852.125.500.150]
- Receptors, Virus [D12.776.543.750.830]
- Receptors, HIV [D12.776.543.750.830.700]
- CX3C Chemokine Receptor 1 [D12.776.543.750.830.700.315]
Below are MeSH descriptors whose meaning is more specific than "CX3C Chemokine Receptor 1".
This graph shows the total number of publications written about "CX3C Chemokine Receptor 1" by people in this website by year, and whether "CX3C Chemokine Receptor 1" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2003 | 0 | 1 | 1 |
| 2017 | 0 | 2 | 2 |
| 2019 | 0 | 1 | 1 |
| 2023 | 0 | 1 | 1 |
| 2024 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "CX3C Chemokine Receptor 1" by people in Profiles.
-
Mild Hypoxia Accelerates Cerebral Cavernous Malformation Disease Through CX3CR1-CX3CL1 Signaling. Arterioscler Thromb Vasc Biol. 2024 06; 44(6):1246-1264.
-
Predictive and Prognostic Implications of Circulating CX3CR1+ CD8+ T Cells in Non-Small Cell Lung Cancer Patients Treated with Chemo-Immunotherapy. Cancer Res Commun. 2023 03; 3(3):510-520.
-
Single-cell analysis of fate-mapped macrophages reveals heterogeneity, including stem-like properties, during atherosclerosis progression and regression. JCI Insight. 2019 02 21; 4(4).
-
IL-17A induces heterogeneous macrophages, and it does not alter the effects of lipopolysaccharides on macrophage activation in the skin of mice. Sci Rep. 2017 09 29; 7(1):12473.
-
Inflammatory Ly6Chi monocytes and their conversion to M2 macrophages drive atherosclerosis regression. J Clin Invest. 2017 Aug 01; 127(8):2904-2915.
-
Fractalkine (CX3CL1) stimulated by nuclear factor kappaB (NF-kappaB)-dependent inflammatory signals induces aortic smooth muscle cell proliferation through an autocrine pathway. Biochem J. 2003 Jul 15; 373(Pt 2):547-58.